Sarah E. James

508 total citations
23 papers, 359 citations indexed

About

Sarah E. James is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Sarah E. James has authored 23 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in Sarah E. James's work include Esophageal Cancer Research and Treatment (4 papers), Breast Cancer Treatment Studies (4 papers) and Global Cancer Incidence and Screening (3 papers). Sarah E. James is often cited by papers focused on Esophageal Cancer Research and Treatment (4 papers), Breast Cancer Treatment Studies (4 papers) and Global Cancer Incidence and Screening (3 papers). Sarah E. James collaborates with scholars based in United States, South Korea and Switzerland. Sarah E. James's co-authors include Qun Lu, Shelagh Brumfitt, Michael G. Haddock, Kenneth W. Merrell, Christopher L. Hallemeier, Youmei Xie, Kwonseop Kim, Tao Yang, Hangun Kim and Stephen M. Massa and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Sarah E. James

19 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah E. James United States 10 142 102 92 61 36 23 359
Stephen Lowe United States 12 42 0.3× 147 1.4× 64 0.7× 48 0.8× 15 0.4× 34 415
Adrian J. Correa United States 8 98 0.7× 111 1.1× 36 0.4× 166 2.7× 20 0.6× 16 408
Pierre-Olivier Gaudreau Canada 7 107 0.8× 116 1.1× 12 0.1× 201 3.3× 11 0.3× 18 424
Hui-Ju Ch'ang Taiwan 10 31 0.2× 145 1.4× 16 0.2× 86 1.4× 12 0.3× 11 391
Paula Warren United States 9 107 0.8× 123 1.2× 19 0.2× 75 1.2× 86 2.4× 18 492
Jason Domogauer United States 10 49 0.3× 129 1.3× 10 0.1× 59 1.0× 34 0.9× 22 365
V. D’Angelo Italy 16 59 0.4× 170 1.7× 67 0.7× 41 0.7× 30 0.8× 39 545
Angela Baker United Kingdom 8 69 0.5× 199 2.0× 27 0.3× 9 0.1× 150 4.2× 14 375
Neel Sharma United Kingdom 11 69 0.5× 171 1.7× 74 0.8× 75 1.2× 22 0.6× 39 437
D. Blackinton United States 8 82 0.6× 109 1.1× 52 0.6× 110 1.8× 9 0.3× 11 357

Countries citing papers authored by Sarah E. James

Since Specialization
Citations

This map shows the geographic impact of Sarah E. James's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah E. James with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah E. James more than expected).

Fields of papers citing papers by Sarah E. James

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah E. James. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah E. James. The network helps show where Sarah E. James may publish in the future.

Co-authorship network of co-authors of Sarah E. James

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah E. James. A scholar is included among the top collaborators of Sarah E. James based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah E. James. Sarah E. James is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Riggan, Kirsten A., et al.. (2025). Psychological Safety in the Medical Care of Black Breast and Ovarian Cancer Patients and Families. Psycho-Oncology. 34(3). e70127–e70127.
2.
Toesca, Diego A.S., Christopher J. Kutyreff, Nathan Y. Yu, et al.. (2024). Evaluation of knowledge‐based planning models for male pelvic CBCT‐based online adaptive radiotherapy on conventional linear accelerators. Journal of Applied Clinical Medical Physics. 25(9). e14464–e14464. 3 indexed citations
3.
Riggan, Kirsten A., et al.. (2023). Cancer Screening Experiences of Black Breast and Ovarian Cancer Patients and Family Members. Journal of Community Health. 48(5). 882–888. 1 indexed citations
4.
Kang, Yixiu, Martin Bues, Michele Y. Halyard, et al.. (2023). Dose delivery reproducibility for PBS proton treatment of breast cancer patients with and without mask immobilization. Radiation Oncology. 18(1). 157–157.
5.
Riggan, Kirsten A., et al.. (2023). “There's not enough studies”: Views of black breast and ovarian cancer patients on research participation. Cancer Medicine. 12(7). 8767–8776. 15 indexed citations
6.
Lin, Steven H., Kenneth W. Merrell, Jincheng Shen, et al.. (2017). Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancer. Radiotherapy and Oncology. 123(3). 376–381. 69 indexed citations
7.
Lester, Scott C., Steven H. Lin, Michael D. Chuong, et al.. (2017). A Multi-institutional Analysis of Trimodality Therapy for Esophageal Cancer in Elderly Patients. International Journal of Radiation Oncology*Biology*Physics. 98(4). 820–828. 30 indexed citations
8.
Biswas, Tithi, et al.. (2016). Inflammatory TNBC Breast Cancer: Demography and Clinical Outcome in a Large Cohort of Patients With TNBC. Clinical Breast Cancer. 16(3). 212–216. 17 indexed citations
9.
Arnett, Andrea, Kenneth W. Merrell, Sarah E. James, et al.. (2016). Utility of 18 F-FDG PET for Predicting Histopathologic Response in Esophageal Carcinoma following Chemoradiation. Journal of Thoracic Oncology. 12(1). 121–128. 21 indexed citations
10.
11.
Biswas, Tithi, et al.. (2014). Inflammatory TNBC breast cancer: Demography and clinical outcome in a large cohort of TNBC patients.. Journal of Clinical Oncology. 32(15_suppl). e12036–e12036. 2 indexed citations
12.
James, Sarah E.. (2013). Common Ground: German Photographic Cultures across the Iron Curtain. Medical Entomology and Zoology. 1 indexed citations
13.
Biswas, Tithi, Timothy M. Zagar, Jimmy T. Efird, et al.. (2013). Insurance status as a strong predictor of outcome in triple-negative breast cancer (TNBC): A multi-institutional retrospective study.. Journal of Clinical Oncology. 31(15_suppl). 1069–1069. 1 indexed citations
14.
He, Yongfeng, Sarah E. James, Qun Lu, et al.. (2012). 14‐3‐3ɛ/ζ Affects the stability of δ‐catenin and regulates δ‐catenin‐induced dendrogenesis. FEBS Open Bio. 3(1). 16–21. 9 indexed citations
15.
James, Sarah E., et al.. (2010). Rho kinase inhibitor Y-27632 facilitates recovery from experimental peripheral neuropathy induced by anti-cancer drug cisplatin. NeuroToxicology. 31(2). 188–194. 20 indexed citations
16.
James, Sarah E., et al.. (2009). Methodology to Obtain a Mixed Sural Nerve Recording in Mice. American Journal of Physical Medicine & Rehabilitation. 88(7). 542–546. 1 indexed citations
17.
James, Sarah E., Hubert W. Burden, Russell Burgess, et al.. (2008). Anti-cancer drug induced neurotoxicity and identification of Rho pathway signaling modulators as potential neuroprotectants. NeuroToxicology. 29(4). 605–612. 59 indexed citations
18.
Kim, Hangun, Jae-Jun Park, Sarah E. James, et al.. (2007). δ-Catenin-induced Dendritic Morphogenesis. Journal of Biological Chemistry. 283(2). 977–987. 62 indexed citations
19.
James, Sarah E., et al.. (1999). Communicating by telephone. Journal of Fluency Disorders. 24(4). 299–317. 29 indexed citations
20.
James, Sarah E.. (1981). Evolution of Real-Time Computer Systems for Manned Spaceflight. IBM Journal of Research and Development. 25(5). 417–428. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephen Lowe Breakdown of academic impact, for papers by Adrian J. Correa Breakdown of academic impact, for papers by Pierre-Olivier Gaudreau Breakdown of academic impact, for papers by Hui-Ju Ch'ang Breakdown of academic impact, for papers by Paula Warren Breakdown of academic impact, for papers by Jason Domogauer Breakdown of academic impact, for papers by V. D’Angelo Breakdown of academic impact, for papers by Angela Baker Breakdown of academic impact, for papers by Neel Sharma Breakdown of academic impact, for papers by D. Blackinton
Rankless by CCL
2026